These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9166865)

  • 1. A transgenic mouse model of hemoglobin S Antilles disease.
    Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM
    Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.
    Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL
    Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced in vivo sickling of transgenic mouse red cells.
    Rubin EM; Witkowska HE; Spangler E; Curtin P; Lubin BH; Mohandas N; Clift SM
    J Clin Invest; 1991 Feb; 87(2):639-47. PubMed ID: 1991848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.
    Monplaisir N; Merault G; Poyart C; Rhoda MD; Craescu C; Vidaud M; Galacteros F; Blouquit Y; Rosa J
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9363-7. PubMed ID: 3467311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.
    Trudel M; Saadane N; Garel MC; Bardakdjian-Michau J; Blouquit Y; Guerquin-Kern JL; Rouyer-Fessard P; Vidaud D; Pachnis A; Roméo PH
    EMBO J; 1991 Nov; 10(11):3157-65. PubMed ID: 1915288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.
    Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic enhancement of polymerization of recombinant sickle hemoglobin mutants: implications for transgenic mouse model for sickle cell anemia.
    Li X; Mirza UA; Chait BT; Manning JM
    Blood; 1997 Dec; 90(11):4620-7. PubMed ID: 9373274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
    Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
    Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a mouse model for sickle cell disease: HB SAD.
    Trudel M; Garel MC; Saadane N; Rouyer-Fessard P; Vidaud D; Costantini F; Beuzard Y
    Nouv Rev Fr Hematol (1978); 1990; 32(6):407-8. PubMed ID: 2101873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.
    He Z; Russell JE
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbS-oman heterozygote: a new dominant sickle syndrome.
    Nagel RL; Daar S; Romero JR; Suzuka SM; Gravell D; Bouhassira E; Schwartz RS; Fabry ME; Krishnamoorthy R
    Blood; 1998 Dec; 92(11):4375-82. PubMed ID: 9834244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine supplementation improves rotorod performance in sickle transgenic mice.
    Fasipe FR; Ubawike AE; Eva R; Fabry ME
    Hematology; 2004 Aug; 9(4):301-5. PubMed ID: 15621739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse alpha chains inhibit polymerization of hemoglobin induced by human beta S or beta S Antilles chains.
    Rhoda MD; Domenget C; Vidaud M; Bardakdjian-Michau J; Rouyer-Fessard P; Rosa J; Beuzard Y
    Biochim Biophys Acta; 1988 Jan; 952(2):208-12. PubMed ID: 3337825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of fully liganded Hb ζ2β2s trapped in a tense conformation.
    Safo MK; Ko TP; Abdulmalik O; He Z; Wang AH; Schreiter ER; Russell JE
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2061-71. PubMed ID: 24100324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human hemoglobins designed for gene therapy of sickle cell disease.
    McCune SL; Reilly MP; Chomo MJ; Asakura T; Townes TM
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9852-6. PubMed ID: 7937904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zeta-globin substitution on the O2-transport properties of Hb S in vitro and in vivo.
    He Z; Russell JE
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1376-82. PubMed ID: 15555579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human sickle hemoglobin in transgenic mice.
    Ryan TM; Townes TM; Reilly MP; Asakura T; Palmiter RD; Brinster RL; Behringer RR
    Science; 1990 Feb; 247(4942):566-8. PubMed ID: 2154033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.